Menopause: Case- based Management
|
|
- Hubert Harmon
- 6 years ago
- Views:
Transcription
1 Menopause: Case- based Management Friday November 11, 2016 Susan Goldstein MD CCFP FCFP NCMP Assistant Professor Department of Family and Community Medicine University of Toronto 1
2 Menarche Menopause: Straw + 10 Final Menstrual Period (FMP) STAGES b - 3a a +1b +1c +2 Terminology MENOPAUSAL REPRODUCTIVE TRANSITION POSTMENOPAUSE Early Peak Late Early Late Early Late PERIMENOPAUSE DuraKon Variable Variable 1-3 yrs 2 yrs (1+1) 3-6 yrs Remaining lifespan PRINCIPAL CRITERIA Menstrual cycle Variable to regular SUPPORTIVE CRITERIA Endocrine FSH AMH Inhibin B Antral Follicle Count DESCRIPTIVE CHARACTERISTICS Symptoms * Blood draw on cycle days 2-5 á = elevated Regular Regular Subtle changes in flow length Low Low Variable Low Low Variable length Persistent 7- day difference in length of consecuove cycles á Variable Low Low Interval of amenorrhea of 60 days á >25 IU/ L** Low Low á Variable Low Low Stabilizes Very low Very low Low Low Low Low Very low Very low 0 Vasomotor symptoms likely Vasomotor symptoms most likely Increasing symptoms of genitourinary syndrome of menopause (GSM) ** Approximate expected level based on assays using current internaoonal pituitary standard Adapted from Harlow et al. Menopause. 2012;19(4):
3 Common Complaints During the Peri- menopause Hot flashes/night sweats Vag dryness/ dyspareunia/ lowered libido Urinary changes Sleep disturbance Depression, anxiety, tension/irritability CogniOve complaints Achy/sOff joints* Rapid HR/PalpitaOons Tingling hands & feet Hair thinning/loss Wt gain Dennerstein, L et al, A prospecove populaoon- based study of menopausal symptoms, Obstet Gynecol, 2000; 96:
4 Genitourinary Syndrome of Menopause (GSM) DefiniKon CollecOon of symptoms and signs associated with estrogen Involves changes to: Ø Labia majora/minora Ø Clitoris Ø VesObule/introitus Ø Vagina Ø Urethra Ø Bladder Symptoms Genital dryness, burning, irritaoon Urinary urgency, dysuria, recurrent UTIs Sexual lack of lubricaoon, discomfort/pain, impaired funcoon *Adopted by the InternaKonal Society for the Study of Women s Sexual Health and NAMS; GSM: genitourinary syndrome of menopause; UTI: urinary tract infeckon. Portman et al. Menopause 2014; 21:
5 MQ The Menopause Quick 6 Screen KEY QuesKons to help address menopausal symptoms: Any changes in your periods? Are you having any hot flashes? Any vaginal dryness or pain or sexual concerns? Any bladder issues/ incononence? How s your sleep? How s your mood? Goldstein, S., Can Fam Physician Pending publication
6 Guidelines & PosiOon Statements 2016 IMS Recommendations on Midlife Women s Health and Menopause Hormone Therapy hkp://dx.doi.org/ / SOGC Guidelines : Managing Menopause (2014) hkp://sogc.org/guidelines/managing- menopause- replaces january- 2009/ NAMS 2016 Hormone therapy PosiKon Statement Pending publica4on NAMS: Statement on ConKnuing Use of Systemic Hormone Therapy A`er Age 65 (2015) hkp:// source/professional/pap- pdf- meno- d minus- trim- cme.pdf NAMS: Nonhormonal management of menopause- associated vasomotor symptoms (2015) hkp:// source/professional/pap- pdf- meno- d minus- trim- cme.pdf
7 Comparison of RelaKve Risk Factors for Breast Cancer Singletary SE, RaOng the risk factors for breast cancer, Ann Surg, 2003;237(4): RelaKve Risk RelaOve Risk Alcohol (2/d) BMI >80%ile EPT aper 5 years Early Menarche (<12) Late Menopause (>55) Nullip/1st child>30 1' relaove PM BrCa>50 1' relaove prem Br Ca
8 RelaOve dosing Product Ultralow Low dose Standard High Dose Premarin (CEE) mg Estrace (E2) 0.5 mg 1 mg Estradot Estraderm Oesclim 25 mcg mcg 50 mcg 50 mcg mcg 100 mcg Climara 25 mcg mcg mcg Estrogel (E2) One pump(.75) 2-4 pumps Divigel (E2).25 gm.5 gm 1 gm ConverOng Between Estrogen Products, Pharmacist's Leker, Nov. 2009
9 An individualized approach to treatment 1. Is MHT indicated? 2. Are there contraindicaoons? 3. Are there comorbidioes? 4. Is there a uterus? 5. When was FMP? 6. Do I need addioonal vaginal ET? Goldstein, S., Can Family Physician, Pending publicaoon
10 MenoPro app The MenoPro app is designed to help women work with their healthcare providers to personalize the management of their menopausal symptoms and to choose the opomal treatment hkps://itunes.apple.com/ca/app/menopro- by- north- american/id ?mt=8
11 WHAT IS THE EVIDENCE FOR NON- HORMONAL TREATMENTS? NAMS 2015 PosiKon Statement: Nonhormonal management of menopause- associated vasomotor symptoms Menopause: Vol. 22, No. 11, 2015 Recommended (good evidence) Recommend with caukon (may benefit, further studies req d) Not Recommended (negakve,insufficient, or conflickng data) SSRI/SNRI (I) Weight loss (II) Exercise/yoga (I) GabapenOnoids (I- II) Soy Isoflavone: S- equol derivaoves (II) Cooling techniques (V) Clonidine (II) Mindfulness based stress reducoon (II) Avoiding triggers (V) CBT (I) Stellate ganglion block (II) Paced respiraoon (I) Hypnosis (I) OTC supps /herbals (I- II) Acupuncture (I) RaKonale: Some intervenkons may have health benefits but may be unlikely to help VMS and will delay appropriate treatment
12 ContraindicaOons to Hormone Therapy ContraindicaKons to HT Unexplained vag bleed Known or suspected Br CA Acute liver dx Acute CVS dx Recent CVA AcOve thromboembolic dx Pregnancy Migraine with aura
13 Co- morbidioes DM Hypertension Smoker Obesity High LIPIDS or other CVS risk Gallstones* MHT is NOT contraindicated, however suggest Transdermal Estrogen
14 Transdermal opoons Estradiol Patches/Gels Patches 2/week: Estradot Estraderm(reservoir) Oesclim Patches 1/week: Climara (weekly) Gels Estrogel (2 pumps is hi) Divigel (low & very low) CombinaKon Products ConKnuous use patches Climara pro (LNG) Estalis (NETA) CombinaKon Gel Estrogel ProPak (MP) Gel 1-25 or 1-21 Prog last 14 days Can use as cononuous
15 ORAL HT FormulaOons In Canada E only* P only E + P combo products CEE (Premarin) E2 (Estrace) MP (Prometrium) MPA (Provera) NETA (Norlutate) CEE + MPA (Premplus) E2 + NETA (AcKvelle, AcKvelle LD) E2 + DRSP (Angelique) TSEC CEE + BZA (Duavive) *No progestogen required in hysterectomized women. HT: hormone therapy; CEE: conjugated equine estrogens; E2: estradiol; EE: esterified estrogens; MP: micronized progesterone; MPA: medroxyprogesterone acetate; NETA: norethindrone acetate; DRSP: drospirenone.
16 TRANSDERMAL HT FormulaOons Available In Canada E only* E2 patch (Climara, Estraderm, Estradot, Oesclim) E2 gel (Divigel, Estrogel) E + P combo products E2 + LNG patch (Climara Pro) E2 + NETA patch (Estalis) E2 gel 0.06% + MP (Estrogel ProPak) *No progestogen required in hysterectomized women. HT: hormone therapy; E2: estradiol; NETA: norethindrone acetate; LNG: levonorgestrel.
17 What to say to paoents (<60 y/o or within 10 yrs of menopause) BENEFITS RISKS Symptom relief: VMS, GSM, PrevenOon of osteoporosis and # May benefit mood, sleep, joint pain, OAB and recurrent UTIs Unpredictable effect on sexual funcoon/libido May reduce risk DM Brain neutral or possible benefit May have CHD/mortality benefit No significant increase in CVA DVT: occurs rarely even in first 1-2 yrs PotenOal breast cancer risk aper 5? years Differs with regimens Will monitor & revisit yearly Oral E may Worsen stress incononence Increased risk of gallstones But Benefits in LDL/HDL There is no absolute Omeline- individualizaoon is key.
18 PaOent Resources SIGMA Canadian Menopause Society Society of Obstetricians and Gynecologists of Canada (SOGC) and menopauseandu.ca North American Menopause Society (NAMS) : Menopro- app!
19 The NAMS Statement on Continuing Use of Systemic Hormone Therapy After Age 65 Menopause. 2015;22(7):693 Provided that the woman has been advised of the increase in risks associated with cononuing HT beyond age 60 and has clinical supervision, extending HT use with the lowest effecove dose is acceptable under some circumstances. Use of HT should be individualized and not discononued solely based on a woman s age.
20 THANK YOU!
Pearls for Menopause Management: I m ready: now what?
Pearls for Menopause Management: I m ready: now what? Friday November 13, 2015 Susan Goldstein MD CCFP FCFP NCMP Assistant Professor Department of Family and Community Medicine University of Toronto Menarche
More informationMenopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationWomen s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationMenopause Symptoms and Management: After Breast Cancer
Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a
More informationHormone Products for Postmenopausal Use in the United States and Canada
Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More informationOrals,Transdermals, and Other Estrogens in the Perimenopause
Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationOVERVIEW OF MENOPAUSE
OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationWhat's New in Menopause Management
Annual Review of Family Medicine December 10, 2015 San Francisco, CA What's New in Menopause Management Michael Policar, MD, MPH Clinical Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine
More informationMenopausal Symptoms The Who: Hot flashes are reported by as many as 75% of perimenopausal women in the U.S.
Menopausal Hormone Therapy: The Who, What, Where, When and Why Laurie Birkholz, MD, NCMP Knowledge of Clinical Trials Regarding Hormone Therapy and Likelihood of Prescribing Hormone Objective: The aim
More information22/09/2014. Menopause Management. Menopause. Menopause symptoms
Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):
More informationAppendix: Reference Table of HT Brand Names
Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug
More informationDeciding whether or not to use Hormone Therapy (HT) is a big decision and should be
Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize
More information11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause
Update on HRT Miss Moneli Golara Consultant Obstetrician and Gynaecologist MBBS, FRCOG Highgate Private Hospital (Barnet Hospital) E: lauren@medicaladministration.co.uk Women s Health Life expectancy of
More informationMENOPAUSAL HORMONE THERAPY 2016
MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.
More informationDisclosures. Objec7ves 9/9/15. What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC.
What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC Disclosures None Objec7ves Discuss terminology of bio- iden7cal, synthe7c and natural hormones.
More informationMenopause management NICE Implementation
Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not
More informationBefore you prescribe
Initiating hormone replacement therapy (HRT) / menopausal hormone therapy (MHT) Dr Sonia Davison Jean Hailes Consultant Endocrinologist Before you prescribe Ensure there are no contraindications to HRT/MHT
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationMenopause Matters. Equity Office Staff Seminar 14 November 2018
Menopause Matters Equity Office Staff Seminar 14 November 2018 1 What to expect at menopause How to manage symptoms Support at work Dr Janice Brown Medical lead, The University of Auckland NZ representative,
More informationThese slides are the property of presenter. Do not duplicate without express written consent.
Menopause & Cancer: Anticipatory Guidance Diana L. Bitner MD 2012 MICHIGAN BCCCP / WISEWOMAN / MCRCEDP ANNUAL MEETING 2 Why Are We Here? Knowledge is power! VS. 3 What is New about Aging? How we age is
More informationPrior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD
Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Predicting the menopause The menopause marks the end of ovarian follicular activity and is said to have occurred after 12 months amenorrhoea. The average age of the menopause is between 45 and 60 years
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationNew Terminology Old Problem!
New Terminology Old Problem! Dr. Chevelta A. Smith Adjunct Professor of LECOM - OB/Gyn March 3, 2018 Discuss the reason behind the development of this new terminology Review the Old Terminology for which
More informationVol-5 No-1 Jan-Mar 2012
"Women's Health" is also available at www.squarepharma.com.bd Editorial Board Dr. Omar Akramur Rab MBBS, FCGP, FIAGP Mohammad Hanif M. Pharm, MBA A.H.M. Rashidul Bari M. Pharm, MBA Executive Editor Chowdhury
More informationQuality of Life. Local Therapy of UG Atrophy. Key Message #1 24/05/2018. Perception of Fears/Problems at Menopause
Disclosure Menopause Webinar May 24, 2018 Gillian Graves Obs Gyn Dalhousie University Retired No Advisory Boards or other industry relations Guidelines Oversight Committee SOGC Royal College Subspecialty
More informationDrug Class Review on Hormone Therapy for Postmenopausal Women or Women in the Menopausal Transition Stage
Drug Class Review on Hormone Therapy for Postmenopausal Women or Women in the Menopausal Transition Stage Final Report Update 3 October 2007 Original Report Date: February 2003 Update 1 Report Date: November
More informationManagement of Menopausal Symptoms
Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationTHE SAFETY CHECK LIST BEFORE STARTING HT
THE SAFETY CHECK LIST BEFORE STARTING HT This safety checklist was designed by the Endocrine Society in 2015 to minimize the chance of giving hormone therapy to women who may be negatively affected by
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationHRT & Menopause Where Do We Stand Now?
HRT & Menopause Where Do We Stand Now? Mrs. SY Hussain Consultant Gynaecologist The Holly Private Hospital Spire Roding Hospital The Wellington Hospital Discussion Points Discuss Recommendations made by
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG Consultant Gynaecologist Heart of England NHS Foundation Trust rajsaha1@yahoo.co.uk Content of today s talk Aims
More information10/2/2017. The 2017 NAMS Hormone Therapy Position Statement has been endorsed by
2017 Hormone Therapy Position Statement JoAnn V. Pinkerton, MD, FACOG, NCMP The North American Menopause Society, Executive Director, Professor of Obstetrics and Gynecology Director, Midlife Health Center
More informationMenopause & HRT. Rosie & Alex. Image:
Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613
More informationMenopause - a summary of management
Page 1 of 5 Menopause - a summary of management Original article by: May Su Resources Menopause treatment algorithm The Jean Hales Foundation for women's heath. Menopause, a treatment algorithm. (Australian
More informationNAMS in the News 2016
NAMS in the News 2016 Menopause in the News This is great support showing that being sedentary is not only not good for your health, it is not good for your menopause symptoms, said Dr. JoAnn Pinkerton,
More informationHormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare
Hormones friend or foe? Undertreatment and quality of life Anette Tønnes Pedersen MD, Ph.D. Consultant, Associate professor Dept. Of Gynecology / Fertility Clinic Rigshospitalet No conflicts of interest
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationEstrogen (conjugated estrogens & ethinyl estradiol) Addition to the List
Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and
More informationScientific Background Report for the 2017 Hormone Therapy Position Statement of The North American Menopause Society
Scientific Background Report for the 2017 Hormone Therapy Position Statement of The North American Menopause Society The 2017 Hormone Therapy Position Statement of The North American Menopause Society
More informationHORMONE REPLACEMENT THERAPY-UPDATE KHALED SAKHEL, MD FACOG FACS FAIUM ASSOCIATE PROFESSOR EASTERN VIRGINIA MEDICAL SCHOOL
HORMONE REPLACEMENT THERAPY-UPDATE KHALED SAKHEL, MD FACOG FACS FAIUM ASSOCIATE PROFESSOR EASTERN VIRGINIA MEDICAL SCHOOL INTRODUCTION NORMAL WOMEN HAVE MENOPAUSE AT A MEAN AGE OF 51 YEARS, WITH 95 PERCENT
More informationMenopause. Pamela S Miles MD Dept. of OB/GYN
Menopause Pamela S Miles MD Dept. of OB/GYN Defining Menopause Defined as the point in time after 12 consecutive months of amenorrhea with no obvious pathologic cause (avg. 52) Peri-menopause/menopause
More informationVirtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11
Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11 Clinical Pearl Post Women's Health Initiative Menopausal Women and Hormone Therapy by JoAnn V. Pinkerton,
More informationMenopause: diagnosis and management NICE guideline NG23. Published November 2015
Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published
More informationMenopause and HRT. John Smiddy and Alistair Ledsam
Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation
More informationSouthern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3
The WISDOM survey: Physicians Level of Comfort Prescribing Treatment for Vulvar and Vaginal Atrophy (VVA) Symptoms in Women with a Predisposition or History of Breast Cancer Lisa Larkin, MD 1 ; Michael
More informationNavigating the Change: Leading Patients Through Menopause
4:30pm - 5:30pm: Breakout 5 - Women s Health Option A: Navigating the Change: Leading Patients Through Menopause ACPE UAN 0107-0000-10-025-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based Program
More informationReal life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study
Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk Case Number 1 - Claire Age
More informationCase Presentation. Learning Objectives. Case Presentation. Case Presentation
Learning Objectives To apply up to date information about the natural history of menopause to improve the care of individual women To counsel women about the risks and benefits of systemic hormone therapy
More informationMenopause & HRT. Matt McKenna Elliot Davis
Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea
More informationBenton Franklin County Medical Society 31st Annual CME Seminar
Management of Current HT/ET and SERM Recommendations Benton Franklin County Medical Society 31st Annual CME Seminar February 21, 2015 Kennewick, Washington Spokane steoporosis Dr. Lynn Kohlmeier Lynn Kohlmeier,
More informationBy Dr Rukhsana Hussain 5 th April 2016
By Dr Rukhsana Hussain 5 th April 2016 1. Is it indicated? Vasomotor symptoms (flushes/sweats) Vaginal atrophy Cycle control (In perimenopause consider low dose COCP (age
More informationResearch Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women
Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms Bungau S 1, Tit DM 1 *, Fodor K 1
More informationEffects of menopause and hormone replacement therapy (HRT) on quality of life of women
Effects of menopause and hormone replacement therapy (HRT) on quality of life of women MD. Nguyen Thi Ngoc Phuong President of the Ho Chi Minh City Reproductive Endocrinology and Infertility Association
More informationFinancial Disclosures
Common Cases and Conundrums in Menopause care Dr. Kerstin Gustafson, MD, FRCSC Financial Disclosures Dr. Kerstin Gustafson, MD, FRCSC, NCMP Speaker fees: Amgen Bayer Merck Novartis Novo-Nordisk Warner-Chilcott
More informationCASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology
CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology A 49-year-old woman complains of irregular menses over the past 6 months, feelings of inadequacy, vaginal dryness, difficulty sleeping, and episodes
More informationGuidelines for Menopause Management
Guidelines for Menopause Management Judith M.E. Walsh, MD, MPH Professor of Medicine UCSF Women s Health Center of Excellence Conflicts of Interest: None Overview Natural history of menopause Hormone therapy:
More information06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:
Menopause Dr Sonia Davison MBBS FRACP PhD Endocrinologist and Clinical Fellow, Jean Hailes for Women s Health Women s Health Research Program, Monash University = the last natural menstrual period depletion
More informationHer serial lab numbers are as follows: all lipid concentrations in mg/dl
LIPID CASE 267 Hormones Lipids and Lipoproteins? On to the case: I was asked about the following patient which will lead into a discussion of using menopausal hormone therapies in women with CV risk. A
More informationTreatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
SPECIAL FEATURE Clinical Practice Guideline Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline Cynthia A. Stuenkel, Susan R. Davis, Anne Gompel, Mary Ann Lumsden,
More informationJames H. Liu, M.D. Arthur H. Bill Professor Chair of Reproductive Biology Dept of Obstetrics and Gynecology
Disclosure Estrogen Therapy After Postmenopausal Hysterectomy: Issues, Challenges, Risks/Benefits James H. Liu, M.D. Arthur H. Bill Professor Chair of Reproductive Biology Dept of Obstetrics and Gynecology
More informationHT: Where do we stand after WHI?
HT: Where do we stand after WHI? Hormone therapy and cardiovascular disease risk Experimental and clinical evidence indicate that hormone therapy (HT) reduces the risk of cardiovascular disease (CVD) Women
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationAPPROACH TO THE MENOPAUSAL PATIENT & CURRENT MANAGEMENT of Menopausal Symptoms
APPROACH TO THE MENOPAUSAL PATIENT & CURRENT MANAGEMENT of Menopausal Symptoms MOA AUTUMN CONFERENCE NOVEMBER 17, 2018 DAVID J BOES, DO, FACOOG BOES@MSU.EDU 1 DISCLOSURES NOTHING TO DISCLOSE RELATIVE TO
More informationWHI Estrogen--Progestin vs. Placebo (Women with intact uterus)
HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric
More informationSex, hormones and the heart
Sex, hormones and the heart Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk #IandA2017 Declaration I have had financial relationships (lecturer, writer, member of advisory boards
More informationBioIdentical Hormone Replacement Therapy for Women
BioIdentical Hormone Replacement Therapy for Women Bio-Identical Hormones are manufactured hormone products from soy or yam. They are changed in a laboratory so that the hormones produced are identical
More informationUpdate on Menopause: What s New?
Karen Carlson, MD Current Clinical Issues in Primary Care 1 Update on Mepause: What s New? Karen Carlson, M.D. Massachusetts General Hospital Harvard Medical School Our agenda: Update on new data from
More informationFOUNDATIONAL PRINCIPLES OF BIO-IDENTICAL HORMONE REPLACEMENT THERAPY: THE WHO, WHAT, WHERE, WHEN, AND WHYS. Dr. Kristy A. Prouse, MD, FRCSC (OB/Gyn)
1 FOUNDATIONAL PRINCIPLES OF BIO-IDENTICAL HORMONE REPLACEMENT THERAPY: THE WHO, WHAT, WHERE, WHEN, AND WHYS Dr. Kristy A. Prouse, MD, FRCSC (OB/Gyn) 2 HOUSEKEEPING Cell Phones Download the Slides Questions
More informationManagement of Patients With Premature Ovarian Insufficiency
Management of Patients With Premature Ovarian Insufficiency Prof. Dr. H. Cavidan Gülerman Sağlık Bilimleri Üniversitesi Ankara Dr. Zekai Tahir Burak SUAM XII. Türk Alman Jinekoloji Kongresi 28 Nisan 2018
More information1/11/2017. Disclosure Statement. Describe the most common medical issues associated with peri-menopause and menopause. Case study:
The Pharmacological Management of Peri-Menopause and Menopause Debora Bear, FNP, MSN, MPH University Of New Mexico Hospital Hormones and other Treatments Gwen Iffil, Stepmber 29, 19 to vember 14, 2016
More informationLessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice
Lessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice JoAnn E. Manson, MD, DrPH, FACP Chief, Division of Preventive Medicine Interim Executive Director, Connors Center Brigham and
More informationEmerging Challenges in Primary Care: Managing Menopause: Update on The Role and Rationale of Hormonal Therapy. Faculty.
Emerging Challenges in Primary Care: 2018 Managing Menopause: Update on The Role and Rationale of Hormonal Therapy Faculty Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP Adult Nurse Practitioner Certified Menopause
More informationManagement of Perimenopausal symptoms
Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts
More informationOverview: Identifying Candidates and Tailoring Treatment. Disclosures 10/6/2014. Vasomotor Symptoms. VMS in Postmenopausal Women
Overview: Identifying Candidates and Tailoring Treatment Risa Kagan, MD, FACOG, CCD, NCMP Clinical Professor, Department of Ob-Gyn, UCSF East Bay Physicians Medical Group Sutter Foundation, Berkeley, CA
More informationNancy R. Berman MSN, ANP-BC, NCMP, FAANP 1950 s: Massive campaign to promote Premarin as a rejuvenating agent and mood
Objectives Comprehensive Menopause Management: An Update on Current Strategies Nancy R. Berman MSN, ANP-BC, NCMP, FAANP Adult Nurse Practitioner/Colposcopist Certified Menopause Practitioner (NAMS) The
More informationOhio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018
Women s Health Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018 Let Your Body Empower You! National Women s Health Week Polycystic Ovary Syndrome Page 2 Breast
More informationIf searching for the book Hot flashes.(clinical Guidelines For Family Physicians)(North American Menopause Society ): An article from: Family
Hot Flashes.(Clinical Guidelines For Family Physicians)(North American Menopause Society ): An Article From: Family Practice News [HTML] [Digital] By Priscilla Latta;Neil Skolnik READ ONLINE If searching
More informationHormone therapy for menopausal vasomotor symptoms
Hormone therapy for menopausal vasomotor symptoms Given our available (better) options for treating hot flashes, can we reduce our use of medroxyprogesterone acetate? OBG Manag. 2014;26(7):10,13 15. Robert
More informationEndocrinology, Menstrual cycle, Menopause and. Prof Bev Lawton (Anna Fenton) Centre for Women s Health Research Victoria Unversity Wellington
Endocrinology, Menstrual cycle, Menopause and Management Prof Bev Lawton (Anna Fenton) Centre for Women s Health Research Victoria Unversity Wellington Female Menstrual Cycle Relevance to psychiatry? Missing
More informationHORMONES AND YOUR HEALTH Charlie Tucker Pharm. D
HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D All of the hormones in your body are designed to work together. This is God s plan. Therefore, if one is altered, or deficient, it will affect the actions
More informationHRT. Responding to questions about. The Women s Health Initiative (WHI) is a large, CME Workshop. associated with combined
CME Workshop Responding to questions about HRT By Margaret Burnett, MD, BA(Hon), MA, CCFP, FRCPC The Women s Health Initiative (WHI) is a large, prospective, placebo-controlled trial sponsored by the National
More informationThe North American Menopause Society (NAMS), a
Menopause: The Journal of The North American Menopause Society Vol. 17, No. 2, pp. 242/255 DOI: 10.1097/gme.0b013e3181d0f6b9 * 2010 by The North American Menopause Society POSITION STATEMENT Estrogen and
More informationNorth American Menopause Society (NAMS)
North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College
More informationPresentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy
Presentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy March 5, 2019 Nese Yuksel, BScPharm, PharmD, FCSHP, NCMP Professor Faculty of Pharmacy and Pharmaceutical
More informationTopics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
More informationManagement of Menopausal Symptoms
Clinical Expert Series Management of Menopausal Symptoms Andrew M. Kaunitz, MD, and JoAnn E. Manson, MD, DrPH Downloaded from https://journals.lww.com/greenjournal by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3K8IvHCABgh/bIG0s8pUeOW5ZlL84rYIWpMvpbO4KRoE=
More informationMenopause 101. Sharzad Green, Pharm.D. Community Clinical Pharmacy
Menopause 101 Sharzad Green, Pharm.D. Community Clinical Pharmacy 1 She has such different moods. One day she is all smiles and happiness. Other days there is no living with her. Throughout a woman s life,
More informationEffects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms
Effects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms Photo (compulsory) Steven R Goldstein, MD 1 ; Ginger D Constantine, MD 2 ; David F Archer, MD 3 ; James H Pickar,
More informationPractical recommendations for hormone replacement therapy in the peri- and postmenopause
CLIMACTERIC 2004;7:in press Practical recommendations for hormone replacement therapy in the peri- and postmenopause Recommendations from an Expert Workshop, February 2004 Henry Burger, Australia; David
More informationGERIATRICS: definitions
Caring For The Modern Menopausal Woman in 2016: An Update on Women s Health In the Geriatric Population David J Boes, DO, FACOOG MSU-COM May 2016 What defines the geriatric population???? GERIATRICS: definitions
More information